PD-1 and CTLA-4: Two checkpoints, one pathway?

    loading  Checking for direct PDF access through Ovid

Abstract

PD-1–centered therapies rely on CD28 activation to promote anti-tumor immunity.

Related Topics

    loading  Loading Related Articles